Targeted Microbiome Transplant in Atopic Dermatitis

NCT03151148 PHASE1, PHASE2 COMPLETED Results posted

The purpose of this study is to examine the safety and effectiveness of a new therapy, commensal lotion containing infection fighting bacteria, on decreasing or eliminating the infection causing bacteria found on the skin of Atopic Dermatitis (AD) patients.

Details

Lead sponsor	National Institute of Allergy and Infectious Diseases (NIAID)
Phase	PHASE1, PHASE2
Status	COMPLETED
Enrolment	54
Start date	Thu Sep 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Jun 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Atopic Dermatitis (AD)

Interventions

• TMT Lotion
• Placebo Lotion

Countries

United States